Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia
2007
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
2009 Standout
Tricuspid valve replacement: Fifteen years of experience with mechanical prostheses and bioprostheses
1995
Thrombotic and Bleeding Complications of Prosthetic Heart Valves
1987
The Role of Blood Component Removal in Essential and Reactive Thrombocytosis
2002
GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia
2016
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
2012
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders
2004
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
CD39 and CD73 in immunity and inflammation
2013 Standout
Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes
2012
Splenectomy for Primary and Recurrent Immune Thrombocytopenic Purpura (ITP)
1987
Endocrine Disruption in Wildlife: A Critical Review of the Evidence
1998 Standout
Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor Beta
2002
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Evaluation and Management of Tricuspid Valve Disease
1991
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Phthalate esters: Occurrence and biological effects
1975
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, abnormal haemoglobins, and thalassaemia in Yugoslavia.
1966
Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
P-glycoprotein plays a drug-efflux–independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway
2000
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Autoimmune thrombocytopenic purpura
1980
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout
Works of Z Rolović being referenced
Late thrombosis of the Björk-Shiley tilting disc valve in the tricuspid position
1986
In vitro drug sensitivity of leukemic progenitors and P‐glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome
1995
Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency
2000
Myelofibrosis in Primary Myelodysplastic Syndromes: Clinical and Biological Significance
2004
Immunologic Abnormalities in Myelodysplastic Syndromes: Clinical Features and Characteristics of the Lymphoid Population
2006
Spontaneous Remission in Adults with Primary Myelodysplastic Syndromes: Incidence and Characteristics of Patients
2005
The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis
1995
[A case of thalassemia minor].
1962
A case of chronic myeloid leukemia without Ph1 translocation
1983
Comparative Studies of the Viability of Human Platelets Stored at 4 C in Plastic and Glass Containers
1967
Megakaryocytopoiesis in Experimentally Induced Immune Thrombocytopenia
1970